Adriana S. Dusso, PhD|
Research Associate Professor of Medicine
Michal Melamed, MD
Assistant Professor, Department of Medicine
Albert Einstein College of Medicine
1300 Morris Park Avenue
Bronx, NY 10461
Kamyar Kalantar-Zadeh, MD, MPH, PhD
Associate Professor of Medicine and Pediatrics
University of California Los Angeles (UCLA)
David Geffen School of Medicine
Board Certified Internist, Nephrologist, and Pediatrician
This group of talks is
accredited for up to
AMA PRA Category 1 credits™. This group of talks has a single post-test,
which must be completed along with an evaluation form to obtain credit. The links to the post-test appear on the individual talk pages.
Date of Web Release:
November 30, 2009
CME Credit Eligible Through: April 30, 2011
AMA PRA Category 1 Credits™:
Target Audiences: Physicians, Researchers and Fellows-in-Training.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.
Patients with moderate to severe CKD have secondary hyperparathyroidism and Vitamin D deficiency. These patients often have advanced vascular disease. In this symposium, we will first explore new insights into the pathophysiology of secondary hyperparathyroidism. Next strategies for early intervention to prevent the development of mineral and bone disorders in CKD patients will be discussed. The final session will discuss the role of vitamin D activators in the management of CKD-MBD including a review of consensus and controversies in the use of these therapeutic agents.
ACCREDITATION AND DESIGNATION STATEMENTS:|
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of
AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in each portion of this activity.
Support for this session is provided by an educational grant from Abbott Laboratories, Inc.
It is the policy of ASN that all individuals in a position to control the content of ASN's sponsored CME activities are expected to provide full disclosure for both themselves and their spouse/partner, and indicate to the activity audience any relevant financial or other relationships held by themselves or their spouse/partner 1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s) discussed in an educational presentation; and 2) with any commercial supporter(s) of the activity. All responses should reflect activities within the previous 12 months. This disclosure information is collected in accordance with the Accreditation Council for Continuing Medical Education (ACCME). Further, ASN requires that all faculty disclose at the time of their lecture, any planned discussion of investigational and/or off-label use of pharmaceutical products or devices within their presentation. Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.
| FACULTY DISCLOSURE STATEMENTS :|
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in continuing medical education (CME), but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.
Faculty disclosures are posted on each individual talk page.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings. Faculty disclosure about unlabeled or off-label use is posted on each individual talk page.
| DISCLOSURE OF UNLABELED USE:|
| ASN's PRIVACY/CONFIDENTIALITY POLICY:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player (download from www.microsoft.com) or
the Flash version 8.0 (download from www.adobe.com) is required, and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send an email to
or email@example.com, or call HDCN at 630-325-3276 during normal business hours, Chicago time (Central Standard Time).
For any general questions concerning ASN CME, please contact the American Society of Nephrology.